Human trials of potential coronavirus vaccine this week, uses new technology

Human trials of potential coronavirus vaccine this week, uses new technology

Funded by the UK government and philanthropic donations.. Scientists at Imperial College London will start the first clinical trials of a potential Covid-19 vaccine this week with more than 45 million pounds ($56.50 million) in backing from the British government and philanthropic donors.. The trials are the first human tests of a new technology which the researchers say could transform vaccine development by enabling rapid responses to emerging diseases such as the Covid-19 infection caused by the new coronavirus.. Robin Shattock, a professor at Imperial's department of infectious disease, said that rather than using a part of the virus, as many vaccines do, this potential vaccine uses synthetic strands of the virus' genetic material - RNA - which are packaged inside tiny fat droplets.. In animal tests, the vaccine was shown to be safe and showed "encouraging signs of an effective immune response", Shattock's team said in a statement.. About 300 healthy volunteers will receive two doses of the vaccine in the initial human trials to test whether it is safe in people and whether it produces an effective immune response against Covid-19.. More than 100 potential vaccines are in development around the world, including several already in human trials